NuPulse

NuPulseCV, Inc., based in Raleigh, NC, is pioneering advancements in the treatment of advanced heart failure through its investigational device, the intravascular ventricular assist system (iVAS). The iVAS is a minimally invasive device designed to support heart function and improve patient outcomes. It is currently being evaluated in clinical trials in the United States and is not yet available for sale. The device aims to allow patients to be discharged from the hospital, thereby improving their quality of life and reducing healthcare costs. NuPulseCV primarily serves patients with advanced heart failure and collaborates with qualified investigators and healthcare providers to ensure the efficacy and safety of its device. The company operates in the medical device market, focusing on innovative solutions for cardiac care. Its business model revolves around the development, clinical evaluation, and eventual commercialization of the iVAS device. Revenue generation is anticipated through the sale of the device upon regulatory approval and widespread adoption in clinical settings.

Keywords: advanced heart failure, intravascular device, minimally invasive, clinical trials, cardiac care, investigational device, patient discharge, healthcare innovation, medical device market, regulatory approval.